Combined Use of Statin and PCSK9 Inhibitor in a Pregnant Woman with Possible Familial Hypercholesterolemia and Coronary Artery Stenosis. [PDF]
Shimizu Y +11 more
europepmc +1 more source
Efficacy of PCSK9 Inhibitors on Clinical Outcomes in Patients with Established Atherosclerotic Cardiovascular Disease: A Network Meta-analysis. [PDF]
Raone L +8 more
europepmc +1 more source
Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study. [PDF]
Wang Y, Huang S.
europepmc +1 more source
Comparative effectiveness of cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis and network meta-regression. [PDF]
Khalil I +16 more
europepmc +1 more source
PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]
Akhtar W +6 more
europepmc +1 more source
Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review. [PDF]
Bashyal S, Karki M, Shah D.
europepmc +1 more source
Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis. [PDF]
Rogozik JK +2 more
europepmc +1 more source
Impact of Age on Lipid-Lowering Therapy Prescriptions and LDL-Cholesterol Control: Insights from the PORTRAIT-DYS Study. [PDF]
Gavina C +8 more
europepmc +1 more source
Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide. [PDF]
Kojima N, Tada H, Takamura M.
europepmc +1 more source
Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.
Dello Strologo A +8 more
europepmc +1 more source

